Gli2 Regulation of Parathyroid Hormone-Related Protein Expression in Metastatic Breast Cancers

Four variations of the PTHrP promoter were tested to determine which yielded the highest PTHrP expression in order to discern which region is most important for Gli2 activation of PTHrP in Tumor-Induced Bone Disease.

Posted by John Lee on Tuesday, December 22nd, 2020 in May 2018, Gli2, Metastatic Breast Cancer, Promoter, PTHrP, Tumor-Induced Bone Disease

Read more